Placenta Accreta Clinical Trial
Official title:
Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta
| Verified date | September 2019 |
| Source | Ain Shams University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.
| Status | Enrolling by invitation |
| Enrollment | 150 |
| Est. completion date | August 30, 2019 |
| Est. primary completion date | August 30, 2019 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years to 39 Years |
| Eligibility |
Inclusion Criteria: - pregnant women with history of scarred uterus - plcenta previa covering the scar of previous caesarean section as diagnosed by 2DU/S - Gestational age from 28wks to full term Exclusion Criteria: - pregnant women with fetus with congenital anomalies - pregnant women with ovarian swelling - pregnant women with medical disease |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Ain shams university maternity hospital | Cairo |
| Lead Sponsor | Collaborator |
|---|---|
| rasha medhat abdul-hady |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Maternal serum alpha-fetoprotein | ng/ml or MOM(Multiple of the median) | From 28weeks to 37 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04579172 -
Conservative Management of Morbidly Adherent Anterior Situated Placenta
|
N/A | |
| Completed |
NCT04593303 -
Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum
|
N/A | |
| Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
| Not yet recruiting |
NCT06100640 -
Paracervical Pouch in Placenta Accreta Spectrum
|
||
| Completed |
NCT05979181 -
Peripartum Cesarean Hysterectomy for Placenta Percreta
|
||
| Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06185894 -
Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery
|
N/A | |
| Completed |
NCT04573452 -
Galectin-3 and Placenta Accreta
|
||
| Not yet recruiting |
NCT03273569 -
PDIUC Protocol for Placental Accreta
|
N/A | |
| Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
| Not yet recruiting |
NCT05104177 -
Effectivness of Conservative Techniques in Management of PAS
|
||
| Completed |
NCT02806024 -
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
|
Phase 4 | |
| Active, not recruiting |
NCT02784886 -
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
|
N/A | |
| Recruiting |
NCT05070689 -
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
|
N/A | |
| Completed |
NCT05813743 -
Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography
|
N/A | |
| Withdrawn |
NCT04003428 -
Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA)
|
N/A | |
| Completed |
NCT04161521 -
Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital
|
N/A | |
| Recruiting |
NCT05139498 -
Conservative Management for PAS Pilot
|
N/A | |
| Not yet recruiting |
NCT03530475 -
Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
|
N/A | |
| Recruiting |
NCT05922397 -
Placenta Accreta Spectrum Topographic Classification
|